International Journal of Clinical Pharmacy

, Volume 39, Issue 4, pp 945–952 | Cite as

General practitioners’ perceptions of the current status and pharmacists’ contribution to primary care in Iceland

  • Anna Bryndis BlondalEmail author
  • Jon Steinar Jonsson
  • Sofia Kälvemark Sporrong
  • Anna Birna Almarsdottir
Research Article


Background For the past several years pharmacists’ responsibilities have expanded globally from traditional tasks of dispensing medications to collaborating with other health care professionals in patient care. Similar developments have not occurred in outpatient settings in Iceland. Objective The aim of this study was to explore Icelandic general practitioners’ views on the current status of primary care, their perceptions of pharmacists as a health care profession, and their attitudes towards future GP-pharmacist collaboration in primary care in Iceland. Setting Twelve primary care clinics in Iceland. Methods Semi-structured in-depth interviews were conducted with general practitioners from different primary care clinics in Iceland. A purposive and snowball sampling technique was used to select participants. All interviews were recorded and transcribed verbatim. The transcripts were categorized by themes and then analyzed using conventional content analysis. Main outcome measure General practitioners’ attitudes towards pharmacists. Results Twenty general practitioners from twelve different primary care clinics in Iceland were interviewed. There are several unmet needs regarding medicines and patient monitoring in the Icelandic health care system. General practitioners suggested ways in which these gaps may be addressed and pharmacist-led clinical service was one of the suggestions. Currently, their communication with pharmacists in the primary sector solely surrounds practical non-clinical issues. Due to increasing polypharmacy and multimorbidity, they suggested that pharmacists should be more involved in patient care. Conclusions General practitioners believe that pharmacist-led clinical service can increase the quality of patient therapy. To improve communication between these health care providers, pharmacists must also re-professionalize (strengthening the profession´s status through new responsibilities and tasks), not having a conflict of interest and showing that they have expertise in patient care.


Attitudes Collaboration General practitioners Pharmaceutical care Pharmacist Primary care 



The authors wish to thank all participants for their contribution to this study.


Funding was provided by University of Iceland, Teaching fund.

Conflicts of interest

The authors declare they have no conflicts of interest to disclose.


  1. 1.
    Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010;7:CD000336.Google Scholar
  2. 2.
    Cipolle RJ, Strand L, Morley P. Pharmaceutical care practice: the patient-centered approach to medication management. 3rd ed. New York: McGraw-Hill Medical; 2012. p. 435–646.Google Scholar
  3. 3.
    Strand LM, Cipolle RJ, Morley PC, Frakes MJ. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des. 2004;10(31):3987–4001.CrossRefPubMedGoogle Scholar
  4. 4.
    Cipolle RJ, Strand L, Morley P, Cipolle R. Pharmaceutical care practice: the clinician’s guide. 2nd ed. New York: McGraw-Hill Medical; 2004.Google Scholar
  5. 5.
    Cipolle RJ, Morley PC, Strand LM. Pharmaceutical care practice. New York: Mcgraw-Hill; 1998.Google Scholar
  6. 6.
    Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K, et al. From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119(5):628–39.CrossRefPubMedGoogle Scholar
  7. 7.
    Almarsdóttir AB. Global perspective: Iceland and Scandinavia. In: Cipolle RJ, Strand LM, Morley PC, editors. Pharmaceutical care practice. 3rd ed. New York: McGraw-Hill Medical; 2012. p. 566–80.Google Scholar
  8. 8.
    Lyfjalög [Pharmaceutical legislation] no. 93/1994. 1994. Accessed 20 Sep 2016.
  9. 9.
    Jonsson H. General practice in Iceland, the present situation. Laeknabladid. 2011;97(5):287.PubMedGoogle Scholar
  10. 10.
    Sigurgeirsdottir S, Waagfjorð J, Maresso A. Iceland: health system review. Health Syst Transit. 2014;16(6):1–182.PubMedGoogle Scholar
  11. 11.
    Calian V, Hardarson O. Statistic Iceland. Mannfjöldaspá 2015–2065 [Population estimate 2015–2065] Mannfjöldaspá 2015–2065 [Population estimate 2015–2065]. 2015. Accessed 10 Dec 2016.
  12. 12.
    Johannsdottir SF, Herbertsson TT. Framreikningar heilbrigðisútgjalda [Future of health care expenditure]. Fjármálatíðindi.2002. Accessed 15 Dec 2016.
  13. 13.
    Hansdottir H, Guðmannsson PG. Lyfjanotkun á hjúkrunarheimilum á Íslandi árin 2002–2004 [Medication in nursing homes in Iceland in 2002–2004]. Laeknabladid. 2013;99:383–6.PubMedGoogle Scholar
  14. 14.
    Sigurðardottir AK, Arnadottir SA, Gunnarsdottir ED. Lyfjanotkun eldri Íslendinga sem búa heima [Medication for the elderly living at home in Iceland]. Laeknabladid. 2011;97:675–80.Google Scholar
  15. 15.
    WHO. Framework for action on interprofessional education and collaborative practice. WHO. Accessed 15 Dec 2016.
  16. 16.
    Bardet J-D, Vo T-H, Bedouch P, Allenet B. Physicians and community pharmacists collaboration in primary care: a review of specific models. Res Soc Adm Pharm. 2015;11(5):602–622.CrossRefPubMedGoogle Scholar
  17. 17.
    Martins SF, van Mil JWF, da Costa FA. The organizational framework of community pharmacies in Europe. Int J Clin Pharm. 2015;37(5):896–905.CrossRefPubMedGoogle Scholar
  18. 18.
    Tan ECK, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Soc Adm Pharm. 2014;10(4):608–22.CrossRefPubMedGoogle Scholar
  19. 19.
    Lauffenburger JC, Vu MB, Burkhart JI, Weinberger M, Roth MT. Design of a medication therapy management program for Medicare beneficiaries: qualitative findings from patients and physicians. Am J Geriatr Pharmacother. 2012;10(2):129–38.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Ageing AGD. Home medicines review program qualitative research project final report. Australian Government Department of Health and Ageing. Accessed 25 Aug 2013.
  21. 21.
    Rubio-Valera M, Jové AM, Hughes CM, Guillen-Solà M, Rovira M, Fernández A. Factors affecting collaboration between general practitioners and community pharmacists: a qualitative study. BMC Health Serv Res. 2012;12:188.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    McGrath SH, Snyder ME, Dueñas GG, Pringle JL, Smith RB, McGivney MS. Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis. J Am Pharm Assoc. 2010;50(1):67–71.CrossRefGoogle Scholar
  23. 23.
    Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.CrossRefPubMedGoogle Scholar
  24. 24.
    Traulsen JM, Bissel P. (9) Theories of professions and the pharmacist. Int J Pharm Pract. 2004;12(2):107–14.CrossRefGoogle Scholar
  25. 25.
    Carlsson JR, Renberg T, Sporrong SK. Drug experts of the future, today?—depiction of the pharmacist profession in Swedish professional and lay print media. Res Soc Adm Pharm. 2012;8(2):133–44.CrossRefGoogle Scholar
  26. 26.
    Birenbaum A. Reprofessionalization in pharmacy. Soc Sci Med. 1982;16(8):871–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Bradley F, Ashcroft DM, Noyce PR. Integration and differentiation: a conceptual model of general practitioner and community pharmacist collaboration. Res Soc Adm Pharm. 2012;8(1):36–46.CrossRefGoogle Scholar
  28. 28.
    Hatah E, Braund R, Duffull SB, Tordoff J. General practitioners’ views of pharmacists’ current and potential contributions to medication review and prescribing in New Zealand. J Prim Health Care. 2013;5(3):223–33.PubMedGoogle Scholar
  29. 29.
    Bradley F, Elvey R, Ashcroft DM, Hassell K, Kendall J, Sibbald B, et al. The challenge of integrating community pharmacists into the primary health care team: a case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration. J Interprof Care. 2008;22(4):387–98.CrossRefPubMedGoogle Scholar
  30. 30.
    Muijrers PE, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RP. Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist. Pharm World Sci. 2003;25(5):235–41.CrossRefPubMedGoogle Scholar
  31. 31.
    Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53(493):600–6.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Kelly DV, Bishop L, Young S, Hawboldt J, Phillips L, Keough TM. Pharmacist and physician views on collaborative practice: findings from the community pharmaceutical care project. Can Pharm J. 2013;146(4):218–26.CrossRefGoogle Scholar
  33. 33.
    Pojskic N, MacKeigan L, Boon H, Ellison P, Breslin C. Ontario family physician readiness to collaborate with community pharmacists on drug therapy management. Res Soc Adm Pharm. 2011;7(1):39–50.CrossRefGoogle Scholar
  34. 34.
    Alkhateeb FM, Clauson KA, McCafferty R, Latif DA. Physician attitudes toward pharmacist provision of medication therapy management services. Pharm World Sci. 2009;31(4):487–93.CrossRefPubMedGoogle Scholar
  35. 35.
    Svensberg K, Sporrong SK, Håkonsen H, Toverud E-L. “Because of the circumstances, we cannot develop our role”: norwegian community pharmacists’ perceived responsibility in role development. Int J Pharm Pract. 2014;23(4):256–65.CrossRefGoogle Scholar
  36. 36.
    Bryant LJM, Coster G, Gamble GD, McCormick RN. General practitioners’ and pharmacists’ perceptions of the role of community pharmacists in delivering clinical services. Res Soc Adm Pharm. 2009;5(4):347–62.CrossRefGoogle Scholar
  37. 37.
    NHS England; Clinical pharmacists in general practice [Internet]. NHS England. Accessed 15 Feb 2017.
  38. 38.
    Blondal AB, Jonsson JS, Spoorong SK, Almarsdottir AB. Introducing pharmaceutical care to primary care in Iceland—an action research study. Pharmacy. 2017;5(2):23. doi: 10.3390/pharmacy5020023.CrossRefGoogle Scholar
  39. 39.
    Molleman E, Broekhuis M, Stoffels R, Jaspers F. Complexity of health care needs and interactions in multidisciplinary medical teams. J Occup Organ Psychol. 2010;83(1):55–76.CrossRefGoogle Scholar
  40. 40.
  41. 41.
    Nordic Medico-Statistical Committee (NOMESCO). Health Statistics for the Nordic Countries 2016. Accessed 5 May 2017.
  42. 42.
    Ministry of Welfare Iceland. Lykiltölur um heilbrigðisumdæmi og heilbrigðisstofnanir [Key figures on health institutions and health regions]. Accessed 9 May 2017.
  43. 43.
    Icelandic Medicine Agency. List of pharmacies/pharmacy outlets. Accessed 9 May 2017.
  44. 44.

Copyright information

© Springer International Publishing 2017

Authors and Affiliations

  • Anna Bryndis Blondal
    • 1
    Email author
  • Jon Steinar Jonsson
    • 2
  • Sofia Kälvemark Sporrong
    • 3
  • Anna Birna Almarsdottir
    • 3
  1. 1.Faculty of Pharmaceutical SciencesUniversity of IcelandReykjavikIceland
  2. 2.Department of Family MedicineUniversity of IcelandReykjavikIceland
  3. 3.Department of PharmacyUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations